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Background: Our previous report that the Norwalk virus nonstructural protein p22 is an antagonist of the cellular
secretory pathway suggests a new aspect of norovirus/host interaction. To explore conservation of function of this
highly divergent calicivirus protein, we examined the effects of p22 homologues from four human and two murine
noroviruses, and feline calicivirus on the secretory pathway.
Findings: All human noroviruses examined induced Golgi disruption and inhibited protein secretion, with the
genogroup II.4 Houston virus being the most potent antagonist. Genogroup II.6 viruses have a conserved mutation
in the mimic of an Endoplasmic Reticulum export signal (MERES) motif that is highly conserved in human norovirus
homologues of p22 and is critical for secretory pathway antagonism, and these viruses had reduced levels of Golgi
disruption and inhibition of protein secretion. p22 homologues from both persistent and nonpersistent strains of
murine norovirus induced Golgi disruption, but only mildly inhibited cellular protein secretion. Feline calicivirus p30
did not induce Golgi disruption or inhibit cellular protein secretion.
Conclusions: These differences confirm a norovirus-specific effect on host cell secretory pathway antagonism by
homologues of p22, which may affect viral replication and/or cellular pathogenesis.
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The Caliciviridae consists of five genera of (+)ssRNA
viruses. The genus Norovirus contains the human noro-
viruses (NoV) that are the predominant cause of gastro-
enteritis in the US [1] and globally [2]. Norovirus is
divided into five genogroups (GI-GV) and most human
NoV fall within GI and GII [3]. Genogroups are further
subdivided into genotypes; genotype GII.4 NoV are cur-
rently the most frequently detected in humans [4]. Gen-
ogroup V contains murine norovirus (MNV), which is
lethal to STAT1−/− mice [5]. The genus Vesivirus con-
tains feline calicivirus (FCV), a cause of severe respira-
tory disease in cats.* Correspondence: mestes@bcm.edu
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reproduction in any medium, provided the orThe nonstructural protein p22 from Norwalk virus
(NV), the prototype NoV, encodes a novel and well-
conserved motif that mimics a traditional di-acidic ER
export signal [6]. This mimic of an Endoplasmic
Reticulum (ER) export signal (MERES) motif allows p22
to gain access to COPII vesicles and is necessary but not
sufficient to antagonize COPII vesicle trafficking to in-
duce Golgi disassembly and inhibit cellular protein se-
cretion. Since NV, MNV and FCV all induce Golgi
disruption [6-8], we compared calicivirus homologues of
p22 for the following: sequence similarity, including con-
served motifs; cellular distribution and location follow-
ing expression; ability to induce Golgi disassembly; and
inhibition of cellular protein secretion. We examined
human NoV homologues of p22, referred to as “p22-like
proteins” (p22L), from the GI.1 NV, the GII.4 Houston
virus (HOV) [9], the GII.3 Saitama U201 [10], and the
GII.6 Cuernavaca 2007 (CNV07) [11]. We also examinedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(CW3 [13]) strains (cDNA provided by “Skip” Virgin of
Washington University), and FCV p30 (cDNA provided
by John Parker of Cornell University), which are all
homologues of p22 [14].
Phylogeny confirmed distinctions [10] between p22
homologues based on genus, genogroup and genotype
(Figure 1A). Amino acid (aa) conservation was ~1% (3 ofFigure 1 Relatedness of calicivirus homologues of NV p22. Calicivirus h
CLUSTALW amino acid alignment (B). CNV07 is Cuernavaca 2007 [GenBank
Saitama U201 virus [GenBank:AB039782], NV is Norwalk virus [GenBank:NC_
[sequence is identical to [GenBank:EU004676] except for one amino acid ch
[GenBank:EF014462], respectively, and FCV is feline calicivirus strain Urbana
membrane association domains as predicted by PSIPRED (available online a
the MERES motif. (C) Amino acids 65–71 of NV p22 were aligned with noro
Children’s Hospital 1997 [GenBank:GU930737]; U3 [GenBank:AB039776], U4
AB039779], U25 [GenBank:AB039780], Neustrelitz260 [GenBank:AY772730] a
conserved residues, : indicates strong group conservation, and . indicates w275 residues) in caliciviruses and 13% (26 of 201 resi-
dues) in human NoV [6]; nonetheless, two conserved
motifs were identified. First, an amphipathic α-helix is
present in human NoV and MNV p22 homologues cor-
responding to the membrane association domain (MAD)
between aa 112–127 of p22 (Figure 1B). FCV p30 lacks a
MAD in this region, but a predicted C terminal amphi-
pathic α-helix may mediate membrane association [15].omologues of NV p22 were compared by phylogeny (A) or
:GU937002], HOV is Houston virus [GenBank:EU310927], U201 is
001959], MNV-CR6 and –CW3 are murine norovirus strains CR6
ange (D50G) (personal communication, “Skip” Virgin)] and CW3
[GenBank:L40021]. Underlined amino acids indicate predicted
t http://www.psipred.net/psiform.html). Bolded amino acids indicate
virus p22L that lack full MERES motif conservation. TCH97 is Texas
[GenBank:AB039777], U16 [GenBank:AB039778], U17 [GenBank:
nd Leverkusen267 [GenBank:EU424333]. In B and C, * indicates
eak group conservation.
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all calicivirus homologues of p22. Second, a conserved
YXΦESDG MERES motif (where X is any amino acid
and Φ is a bulky, hydrophobic residue [e.g. M, I or L])
was present in 92% (65 of 72) of NoV p22L, of which
the Y and E residues are most important to secretory
pathway antagonism [6]. This motif is absent in MNV
p18 and FCV p30.
Of seven identified human NoV that lack the full
MERES motif, four belong to GII.6 isolated from differ-
ent individuals during a single outbreak [10] and encode
either YRVSSDG or YRVSSNG in the MERES motif
(Figure 1C). The fifth is an untyped GII NoV that also
encodes YRVSSDG, the sixth is a GII.8 NoV that
encodes YRISSDG, and finally a GII.16 NoV encodes
FDLESDG. We sequenced the p22L of two additional
GII.6 NoV, CNV07 [11] and TCH97 E99-13646, the lat-
ter of which was isolated from an infant male hospita-
lized with gastroenteritis at Texas Children’s Hospital in
1997. Both viruses encode the same YRVSSNG sequence
as other GII.6 NoV, demonstrating retention of the E68S
MERES motif mutation in GII.6 NoV from at least 1997
through 2007.Figure 2 Localization and effect of norovirus homologues of NV p22
indicated proteins and immuno-stained for the cis Golgi or ER marker prote
antibody, red fluorescence). Nuclei were counterstained with DAPI (blue flu
in C indicates a mitotic cell, and “U201 p22LΔ” has the MERES motif mutatTo assess the importance of the MERES motif in
secretory pathway antagonism, the cellular distribution
and location of N terminal GFP tagged calicivirus homo-
logues of NV p22 and the Golgi phenotype were exam-
ined following expression in mammalian cells. At 24
hours post-transfection (hpt), 100% of GFP expressing
cells had well-condensed Golgi proximal to nuclei
(Figure 2A). Similar to cells expressing NV p22
(Figure 2B) [6], U201 p22L localized to discrete puncta,
of which 93% contained phenotypically disrupted Golgi
present solely in disordered puncta throughout the cell,
similar to Golgi fragmentation in mitotic cells
(Figure 2C, top panels, asterisk) [16]. Mutation of the
U201 p22L MERES motif to YXΦAAAA resulted in co-
localization with the ER marker protein calnexin
(Figure 2C, bottom panels), as did p22 containing a
similar mutation [6]. This demonstrated a conserved
function for the MERES motif in trafficking p22L away
from the ER and towards the Golgi. The Golgi in all cells
expressing HOV p22L was disrupted (Figure 2D, top
panels). HOV p22L localized more diffusely throughout
cells without the reticular distribution characteristic of
ER localization (Figure 2D, bottom panels) and with fewon the Golgi apparatus. 293T cells were transfected to express the
ins GM130 and calnexin, respectively (Alexa-Fluor 594 secondary
orescence) and cells were imaged by deconvolution microscopy. The *
ed to encode YXΦAAAA in place of the MERES motif.
Figure 3 FCV p30 is ER localized and does not induce Golgi
disruption. CRFK cells were transfected to express GFP or GFP-
tagged PV 3A, NV p22 or FCV p30 and immuno-stained (Alexa-Fluor
594 secondary antibody, red fluorescence) for the cis Golgi marker
protein GM130 (A) or the ER marker protein disulfide isomerase (PDI)
(B). Nuclei were counterstained with DAPI (blue fluorescence) and
cells were imaged by deconvolution microscopy.
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of cells expressing CNV07 p22L had phenotypically dis-
rupted Golgi, and GFP-tagged protein localized to both
the Golgi (Figure 2E, top panels) and ER (Figure 2E, bot-
tom panels), demonstrating an intermediate localization
of CNV07 p22L. Similar levels of all p22L by western
blot at 24 hpt indicated that differences in Golgi pheno-
type are not due to differences in protein expression
levels (data not shown).
Due to inefficient transfection of macrophages, MNV
p18 was expressed in 293T cells to evaluate p18
localization and effect on the Golgi. p18 from MNV
strains CW3 and CR6 induced Golgi disruption in 94%
and 97% of cells, respectively (Figure 2F). In contrast to
p22, MNV p18 puncta co-localized with the peri-nuclear
remnants of the Golgi, suggesting that p18 associates
with the Golgi despite disruption.
FCV p30 localizes to and induces ultrastructural
changes in the ER and may affect secretory pathway func-
tion [15]. Non-transfected or GFP-expressing feline CRFK
cells exhibited phenotypically normal Golgi, but the Golgi
was dispersed in cells expressing poliovirus (PV) 3A, a
well-known secretory pathway antagonist [17-20], and
fragmented in cells expressing p22 (Figure 3A). FCV p30
did not induce alterations in Golgi phenotype, but instead
exhibited a reticular ER localization (Figure 3B).
To determine if the observed phenotypic changes in
Golgi architecture resulted in changes in secretory path-
way trafficking, antagonism of the secretory pathway
was examined with the SEAP assay, an enzymatic surro-
gate for cellular protein secretion [21]. Proteins were
expressed from the di-cistronic vector pCMV-UTR-
SEAP with N terminal GFP tags and SEAP secretion was
quantitated as previously described [6]. At 24 hpt, p22
reduced SEAP secretion to ~50%, representing a 32% re-
duction in protein secretion compared to GFP alone;
mutation of the Y and E residues of the MERES motif in
p22 restored SEAP secretion (Figure 4A). p22L from
U201 and HOV inhibited SEAP secretion significantly
more than NV p22 (p ≤ 0.002) to 44 and 39%, respect-
ively, or 39 and 46% of GFP alone, respectively. Al-
though CNV07 p22L inhibited SEAP secretion by 28%
compared to GFP alone, inhibition was significantly less
than that of p22 (p = 0.03). Thus, in line with observa-
tions of Golgi disruption, HOV p22L was the strongest
inhibitor of protein secretion and CNV p22L was the
weakest.
p18 from persistent (CR6) and nonpersistent (CW3)
MNV strains both inhibited protein secretion signifi-
cantly less (10% compared to GFP) than p22
(p ≤ 0.0002). FCV p30 did not reduce SEAP secretion in
CRFK cells at 24 hpt compared to GFP alone (p = 0.44),
although PV 3A efficiently inhibited SEAP secretion
(p = 0.00002) (Figure 4B); CRFK cells did not expressp22 in sufficient quantity to allow quantitation of SEAP
secretion (data not shown).
These results demonstrate that all NoV p22L examined
inhibit cellular protein secretion, but to different extents
and with differences in cellular localization. Most interest-
ing is the reduction of inhibition seen for CNV07 p22L,
which has a natural mutation in the MERES motif. Inhib-
ition of SEAP secretion similarly occurs at intermediate
levels when a E68A mutation is made in NV p22 [6], sug-
gesting a causal relationship between this mutation and
Figure 4 Effect of calicivirus homologues of NV p22 on cellular protein secretion. 293T (A) or CRFK (B) cells were transfected with the
vector pCMV-UTR-SEAP expressing the indicated proteins with N terminal GFP tags. Cells were washed and fresh medium was added at 22
hours-post transfection (hpt). At 24 hpt the media (containing extracellular SEAP) was collected, cells were washed 2X in cold 0.01M PBS and
lysed in media containing 0.1% Triton X-100 (yielding the intracellular SEAP fraction). SEAP secretion was calculated by assaying both fractions for
enzymatic SEAP activity, which were then used in the equation: SEAP secretion (%) = (SEAPextracellular/[SEAPextracellular + SEAPintracellular]) x 100. Data
are representative of at least two experiments; n = 3 for each sample; errors bars indicate standard deviations. One hundred percent of the cells
expressing p22 homologue-EGFP and SEAP were viable as assessed by trypan blue exclusion (0.2% final concentration for 5 min) at 24 hpt.
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Nonetheless, the biological significance of secretory path-
way antagonism by NoV p22L, as well as the differences
between them in level of inhibition, remains to be
elucidated.
Future studies to examine the 20 amino acids con-
served between all NoV p22L that are not part of the
MERES motif or MAD may assist in identifying the sec-
ond factor required to mediate secretory pathway antag-
onism [6]. Additional information may be obtained by
comparing NoV p22L with MNV p18, as p18 does not
encode the MERES motif but still localizes to the Golgi
and disrupts it ([22] and Figure 2). However, lack of the
MERES motif in p18 correlates with reduced efficiency
of protein secretion inhibition, although Golgi disruption
still occurs. This suggests that the MERES motif assists
in secretory pathway antagonism by p22L, whereas Golgi
disruption is mediated by a region of p22L outside of
this motif. This relationship also holds true for FCV p30,
which lacks the MERES motif and does not inhibit pro-
tein secretion or induce Golgi disruption. Comparison of
residues conserved in p22L from NoV and MNV that
are absent in FCV will assist in identifying the residues
responsible for Golgi disruption.
MNV p18 from persistent and nonpersistent strains
had a similar effect on the secretory pathway, suggesting
that persistence is not attributable to differences in
secretory pathway antagonism by p18. Our result that
p18 induces Golgi disruption in human 293T cells is
consistent with a report that MNV-infected murine
macrophages lack a discernable Golgi [8], and retentionof p18 at Golgi remnants suggests antagonism by inter-
action with a Golgi-localized protein. Indeed, the MNV
replication complex is localized peri-Golgi [23], suggest-
ing a role for p18 in its formation.
Since HOV p22L was the most potent secretory path-
way antagonist examined, it may be that increased inhib-
ition of protein secretion is beneficial to NoV infectivity
or replication. This is supported by the observation that
GII.4 p22L undergo positive selection [24]. This coupled
with the observation that NV-infected individuals make
antibodies specific to p22 ([25] and unpublished obser-
vation) suggests that the high variability of p22L may be
due to evasion of immuno-recognition.
In summary, secretory pathway antagonism by calici-
virus homologues of NV p22 correlates with preserva-
tion of the MERES motif, and many p22 homologues
affect Golgi phenotype. All homologues examined herein
are predicted to be membrane associated, suggesting
that despite varying effects on the secretory pathway
they may have a conserved role in viral replication. Con-
servation of alternate and additional functions for p22
homologues should therefore be explored to more fully
elucidate how caliciviruses interact with their host cells.
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